|4May 13, 4:11 PM ET

Heron Patrick J 4

4 · Arcutis Biotherapeutics, Inc. · Filed May 13, 2025

Insider Transaction Report

Form 4
Period: 2025-05-09
Transactions
  • Purchase

    Common Stock

    2025-05-09$13.60/sh+6,300$85,6916,300 total(indirect: By Frazier Life Sciences X, L.P.)
Holdings
  • Common Stock

    (indirect: By Trust)
    23,688
  • Common Stock

    (indirect: By FHM Life Sciences VIII, L.L.C.)
    7
  • Common Stock

    18,826
  • Common Stock

    (indirect: By Frazier Life Sciences VIII, L.P.)
    8,785,284
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.1504 to $13.9266, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F3]The shares reported herein are held of record by Frazier Life Sciences VIII, L.P. FHM Life Sciences VIII, L.P. is the general partner of Frazier Life Sciences VIII, L.P. and FHM Life Sciences VIII, L.L.C. is the general partner of FHM Life Sciences VIII, L.P. The Reporting Person is one of two managing members of FHM Life Sciences VIII, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F4]The shares reported herein are held of record by FHM Life Sciences VIII, L.L.C. The Reporting Person is one of two managing members of FHM Life Sciences VIII, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F5]The shares are held directly by The Heron Living Trust 11/30/2004. The Reporting Person is the co-trustee of The Heron Living Trust 11/30/2004 and has voting and investment power of the securities held by The Heron Living Trust 11/30/2004.

Documents

1 file
  • 4
    form4-05132025_080532.xmlPrimary